| Ticker | COLL |
|---|---|
| ISIN | US19459J1043 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegiu...
El precio actual de Collegium Pharmaceutical, Inc. (COLL) es de 32,50 , con una variación del 0,68%.
Collegium Pharmaceutical, Inc. opera en el sector Healthcare, industria Drug Manufacturers - Specialty & Generic.